STOCK FUTURES SLIDE AFTER META'S REALITY CHECK, WITH GDP ON DECK

Owner of Facebook and Instagram plans to spend up to US$10B on AI infrastructure investments

Syros Pharmaceuticals, Inc. (SYRS)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD

Add to watchlist

5.07

-0.07

(-1.36%)

At close: 04:00PM EDT

5.30

+0.23

(+4.54%)

Pre-Market:

08:47AM EDT

Currency in USD

Earnings Estimate	Current Qtr. (Mar 2024)	Next Qtr. (Jun 2024)	Current Year (2024)	Next Year (2025)
No. of Analysts	5	5	5	5
Avg. Estimate	-0.87	-0.91	-3.69	-3.34
Low Estimate	-1.2	-1.21	-4.77	-4.94
High Estimate	-0.69	-0.69	-2.8	-1.05
Year Ago EPS	-0.85	-1.3	-5.81	-3.69

Revenue Estimate	Current Qtr. (Mar 2024)	Next Qtr. (Jun 2024)	Current Year (2024)	Next Year (2025)
No. of Analysts	5	5	5	5
Avg. Estimate	720k	720k	2.8M	32.08M
Low Estimate	N/A	N/A	N/A	N/A
High Estimate	1.8M	1.8M	7M	130.4M
Year Ago Sales	2.95M	N/A	9.94M	2.8M
Sales Growth (year/est)	-75.60%	N/A	-71.80%	1,045.70%

Earnings History	2023-03-30	2023-06-29	2023-09-29	2023-12-30
EPS Est.	-1.09	-1.13	-1.14	-1.14
EPS Actual	-0.85	-1.3	-1.43	-2.18
Difference	0.24	-0.17	-0.29	-1.04
Surprise %	22.00%	-15.00%	-25.40%	-91.20%

EPS Trend	Current Qtr. (Mar 2024)	Next Qtr. (Jun 2024)	Current Year (2024)	Next Year (2025)
Current Estimate	-0.87	-0.91	-3.69	-3.34
7 Days Ago	-0.87	-0.91	-3.69	-3.34
30 Days Ago	-0.95	-1.05	-4.11	-3.08
60 Days Ago	-0.95	-1.05	-4.11	-3.08
90 Days Ago	-0.95	-1.05	-4.11	-3.08

EPS Revisions	Current Qtr. (Mar 2024)	Next Qtr. (Jun 2024)	Current Year (2024)	Next Year (2025)
Up Last 7 Days	N/A	N/A	N/A	N/A
Up Last 30 Days	3	3	3	2
Down Last 7 Days	N/A	N/A	N/A	N/A
Down Last 30 Days	N/A	N/A	N/A	N/A

Growth Estimates	SYRS	Industry	Sector(s)	S&P 500
Current Qtr.	-2.40%	N/A	N/A	N/A
Next Qtr.	30.00%	N/A	N/A	N/A
Current Year	36.50%	N/A	N/A	N/A
Next Year	9.50%	N/A	N/A	N/A
Next 5 Years (per annum)	N/A	N/A	N/A	N/A
Past 5 Years (per annum)	N/A	N/A	N/A	N/A